J0219 HCPCS code: Injection, avalglucosidase alfa-ngpt, 4 mg
J0219 is the HCPCS Level II code for injection, avalglucosidase alfa-ngpt, 4 mg. In 2024 Medicare paid an average of $59.75 per service for J0219 across 290,003 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 750 per day on outpatient hospital claims. Medicare volume rose 140% from 2022 to 2024 (120,762 to 290,003 services). In 2024, about 91 clinicians billed Medicare for J0219 for 36 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-04-01 |
| Last action effective | 2022-04-01 |
Who bills J0219 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 91 |
| Medicare beneficiaries | 36 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0219, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 120,762 | 24 | $72.59 | $57.86 |
| 2023 | 268,911 | 30 | $72.70 | $57.91 |
| 2024 | 290,003 | 36 | $75.00 | $59.75 |
States with the most J0219 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 109,473 | $60.21 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 750 | Prescribing Information |
| practitioner claims | 750 | Prescribing Information |
What changed for J0219
- 2022-04-01: J0219 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0219?
J0219 is the HCPCS Level II code for injection, avalglucosidase alfa-ngpt, 4 mg. Short descriptor: "Inj aval alfa-nqpt 4mg".
How much does Medicare pay for J0219?
In 2024, the average Medicare payment was $59.75 per service (average allowed $75.00).
Does Medicare cover J0219?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0219 can be billed per day?
750 on outpatient hospital claims; 750 on practitioner claims (NCCI medically unlikely edits).
Related J02 codes
- J0200 — Injection, alatrofloxacin mesylate, 100 mg
- J0202 — Injection, alemtuzumab, 1 mg
- J0205 — Injection, alglucerase, per 10 units
- J0206 — Injection, allopurinol sodium, 1 mg
- J0207 — Injection, amifostine, 500 mg
- J0208 — Injection, sodium thiosulfate (pedmark), 100 mg
- J0209 — Injection, sodium thiosulfate (hope), 100 mg
- J0210 — Injection, methyldopate hcl, up to 250 mg
- J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215 — Injection, alefacept, 0.5 mg
- J0216 — Injection, alfentanil hydrochloride, 500 micrograms
- J0217 — Injection, velmanase alfa-tycv, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0219
- Watch J0219 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0219
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.